PVCT: the balance sheet

MyFinsight

For the year ending 2025-12-31, PVCT has $697,502 in assets. $7,000,220 in debts.

Balance Sheets	2025-12-31
Cash	251,291
Prepaid expenses and other current assets	316,583
Total current assets	567,874
Equipment and furnishings, less accumulated depreciation of 120,013 and 118,151, respectively	3,000
Operating lease right-of-use asset	126,628
Total assets	697,502

Accounts payable	716,220
Accrued interest-Nonrelated Party	23,540
Accrued interest-Related Party	120,384
Other accrued expenses	3,161,379
Notes payable	217,772
Convertible notes payable-Nonrelated Party	870,000
Convertible notes payable-Related Party	1,740,000
Operating lease liability, current portion	48,083
Total current liabilities	6,897,378
Notes payable, non-current portion	23,621
Operating lease liability, non-current portion	79,221
Total liabilities	7,000,220
Preferred stock, value-Series DConvertible Preferred Stock	957
Preferred stock, value-Series DOne Convertible Preferred Stock	14,183
Common stock par value 0.001 per share 1,000,000,000 shares authorized 420,279,879 shares issued and outstanding at december 31, 2025 and 2024	420,280
Additional paid-in capital	256,179,846
Accumulated other comprehensive loss	-60,191
Accumulated deficit	-262,853,812
Total provectus biopharmaceuticals, inc., stockholders deficit	-6,298,737
Non-controlling interest in subsidiary	-3,981
Total stockholders deficit	-6,302,718
Total liabilities and stockholders deficit	697,502

Unit: Dollar.